The COVID-19 pandemic has shattered millions of lives globally and continues to be a
challenge to public health due to the emergence of variants of concern. Fear of secondary …

Fungal infections are a major public health problem resulting from the lack of public policies
addressing these diseases, toxic and/or expensive therapeutic tools, scarce diagnostic tests …

Fungal infections cause more than 1.5 million deaths a year. Due to emerging antifungal
drug resistance, novel strategies are urgently needed to combat life-threatening fungal …

The development of bacterial resistance is an increasing global concern that requires
discovering new antibacterial agents and strategies. Bacterial quorum sensing (QS) systems …

Background. Candida auris has spread rapidly around the world as a causative agent of
invasive candidiasis in health care facilities and there is an urgent need to find new options …

Persistent infections, usually associated with biofilm-producing bacteria, are challenging for
both medical and scientific communities. The potential interest in drug repurposing for …

The repurposing of drugs is one of the most competent strategies for discovering new
antimicrobial agents. Vildagliptin is a dipeptidyl peptidase-4 inhibitor (DPI-4) that is used …

Amid the mounting burden of multidrug-resistant (MDR) bacterial infections on health care
worldwide, drug repurposing, a time and cost-effective strategy to identify new applications …

The emergence of multidrug-resistant (MDR) superbugs underlines the urgent need for
innovative treatment options to tackle resistant bacterial infections. The clinical efficacy of …

The incessant, global increase in antimicrobial resistance (AMR) is a very big challenge for
healthcare systems. AMR is predicted to grow at an alarming pace, with a dramatic increase …